Peripheral Arterial Disease Trial, Recruiting NCT07672249 Sponsor: I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT07672249
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults aged 18 or older, of any sex
  • People who have a significant narrowing or blockage in one or both of the large arteries in the pelvis (the common iliac artery and/or external iliac artery), confirmed by a CT scan, MRI scan, or angiogram
  • People with peripheral artery disease causing leg pain when walking (limiting daily activities) or more severe symptoms such as pain at rest, wounds, or tissue damage, that has not improved with medication alone
  • People whose treatment plan involves placing a stent (a small tube to open the artery) inside the affected iliac artery as the main way to restore blood flow
  • People with a new blockage or narrowing in the artery that has not been treated before
  • People for whom complete medical records and follow-up information are available (confirm with trial site)

Who may not be able to join:

  • People whose planned treatment involves open surgery on the iliac artery, such as a bypass graft or surgical removal of the blockage
  • People who have previously had a stent placed in the same artery being treated
  • People being treated primarily for an aneurysm (a bulge in the artery wall) in the aorta or iliac arteries, including certain types of stent-graft procedures
  • People having a combined procedure that also includes bypass surgery on arteries below the groin at the same time
  • People whose medical, procedure, or follow-up records are incomplete in a way that would prevent the trial from measuring its outcomes
  • People who have been lost to follow-up and have no recorded clinical outcomes after treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 14 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +393458013083

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio
Registry
ClinicalTrials.gov
Start date
16 June 2026
Est. completion
1 July 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Number of Participants Experiencing Major Adverse Limb Events (MALE) Within 12 Months

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 14 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov